Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 4
1994 3
1995 1
1996 1
1997 1
1998 4
1999 2
2000 6
2001 1
2002 5
2003 1
2004 3
2007 2
2008 5
2009 4
2010 1
2011 2
2017 3
2019 1
2020 1
2021 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Novel aspects of natural and modified vinca alkaloids.
Duflos A, Kruczynski A, Barret JM. Duflos A, et al. Among authors: barret jm. Curr Med Chem Anticancer Agents. 2002 Jan;2(1):55-70. doi: 10.2174/1568011023354452. Curr Med Chem Anticancer Agents. 2002. PMID: 12678751 Review.
Antitumor pharmacology -- quo vadis?
Bailly C, Barret JM, Kruczynski A. Bailly C, et al. Among authors: barret jm. Curr Med Chem Anticancer Agents. 2004 Sep;4(5):389-91. doi: 10.2174/1568011043352849. Curr Med Chem Anticancer Agents. 2004. PMID: 15379689 Review.
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression.
Prat M, Le Naour A, Coulson K, Lemée F, Leray H, Jacquemin G, Rahabi MC, Lemaitre L, Authier H, Ferron G, Barret JM, Martinez A, Ayyoub M, Delord JP, Gladieff L, Tabah-Fisch I, Prost JF, Couderc B, Coste A. Prat M, et al. Among authors: barret jm. J Immunother Cancer. 2020 Jun;8(1):e000472. doi: 10.1136/jitc-2019-000472. J Immunother Cancer. 2020. PMID: 32503947 Free PMC article.
ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C, Lazrek Y, Dubreuil O, Sampaio C, Larbouret C, Lanotte R, Poul MA, Barret JM, Prost JF, Pèlegrin A, Chardès T. Le Clorennec C, et al. Among authors: barret jm. Cell Commun Signal. 2019 Aug 23;17(1):106. doi: 10.1186/s12964-019-0413-8. Cell Commun Signal. 2019. PMID: 31443721 Free PMC article.
Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation.
Prat M, Salon M, Allain T, Dubreuil O, Noël G, Preisser L, Jean B, Cassard L, Lemée F, Tabah-Fish I, Pipy B, Jeannin P, Prost JF, Barret JM, Coste A. Prat M, et al. Among authors: barret jm. Cancers (Basel). 2021 Apr 13;13(8):1845. doi: 10.3390/cancers13081845. Cancers (Basel). 2021. PMID: 33924378 Free PMC article.
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer.
Barret JM, Nicolas A, Jarry A, Dubreuil O, Meseure D, Passat T, Perrial E, Deleine C, Champenois G, Gaillard S, Duchalais E, Ray-Coquard I, Lahmar M, Dumontet C, Bennouna J, Bossard C, Roman-Roman S, Prost JF. Barret JM, et al. Biology (Basel). 2021 Apr 7;10(4):305. doi: 10.3390/biology10040305. Biology (Basel). 2021. PMID: 33917111 Free PMC article.
Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
Le Clorennec C, Bazin H, Dubreuil O, Larbouret C, Ogier C, Lazrek Y, Garambois V, Poul MA, Mondon P, Barret JM, Mathis G, Prost JF, Pèlegrin A, Chardès T. Le Clorennec C, et al. Among authors: barret jm. Mol Cancer Ther. 2017 Jul;16(7):1312-1323. doi: 10.1158/1535-7163.MCT-16-0886. Epub 2017 May 15. Mol Cancer Ther. 2017. PMID: 28507002 Free article.
51 results